The value of plasma digitalis determinations will depend upon the accuracy with which they mirror the myocardial effects of digitalis. Ten volunteers received 0.8 mg of digitoxin intravenously, and after 2 hours the mean plasma digitoxin level was 45.6 + 6 m,ug/ml but declined over 4 to 6 hours during plasma-tissue equilibration. The cardiac response, as indicated by decreases in the left ventricular ejection time index (LVETI) and Q-S2 intervals (P < 0.01), was present at 2 hours and reached maximum at 4 to 6 hours. Subsequently, plasma level, LVETI, and Q-S2 changed in the same direction during slow excretion.
Heart rate Systolic interval during the steady state after administration is of the order of at least 1:30.9 10 Thus far, animal experiments and observations on patients considered to be intoxicated with these drugs suggest that plasma concentration reflects the myocardial concentration or effects, or both. 6 8 Prior to widespread application of these new methods, the relationships between the plasma levels of these drugs and their myocardial effects in man should be defined more precisely. A recent study has shown that the electrocardiographic effects of digitoxin and digitalis leaf, short of toxic arrhythmias, are too nonspecific for such purposes.7 Furthermore, the sizable overlap of plasma values between patients considered adequately digitalized and those judged intoxicated" suggests the need for additional correlative investigations.
The purpose of the present study was to attempt to correlate plasma levels of digitoxin and digoxin during the first 2 to 3 days after acute administration with the myocardial effects of these drugs as reflected in the expected alterations in the systolic portion of the cardiac cycle.
Methods

Subjects
Ten patients and six medical students volunteered for study. Mean age for the 10 patients was 44.6 years (range, 35 to 55); the mean age of the six students was 25 years (range, 24 to 26). Fourteen of the 16 subjects had no evidence of cardiovascular disease. The two cardiac patients had the following conditions: alcoholic cardiomyopathy (subject 1) and mild mitral stenosis (subject 2). None of these patients or students had previously received digitalis; all had normal serum electrolyte determinations at the time of study.
Measurement of Plasma Digitoxin and Digoxin
The technic longest used in our Recently a major modification of the 86Rb method designed to increase its accuracy for digoxin was reported by Grahame-Smith and Everest.5 It was employed for plasma digoxin determinations with the following alterations: (1) Centrifugations were carried out at room temperature; (2) 2.5 uc of rubidium radioactivity was added to each sample; and (3) every calibration curve point and each unknown or patient sample was carried out in duplicate. The data from a given run were expressed as the mean of these duplicate determinations. Calculations and counting were carried out as described above.
Determinations of Systolic Intervals
Recording and measurement of systolic intervals were carried out as described by Weissler and Circulation, Volume XLII, December 1970 colleagues12 utilizing the following equipment. Recordings were made on a research recorder with a direct-writer attachment at a paper speed of 100 mm/sec. Lead II of the electrocardiogram was recorded in standard fashion. Heart sounds at the apex were recorded with the patient recumbent utilizing a model PS-1 pulse sound microphone (Electronics for Medicine, Inc.). The carotid pulse tracings were obtained by utilizing a Hewlett-Packard, model APT-16 coil pickup. Analyses were carried out for heart rate, preejection period (PEP), left ventricular ejection time (LVET), Q-S2, Q-1, and left ventricular ejection time index (LVETI). The pre-ejection period and Q-S2 interval were corrected for heart rate according to the regression curves published by Weissler and associates.13 Calculations for ejection fraction (EF) were carried out according to the method of Garrard and co-workers14 which has shown a correlation coefficient of 0.88 between angiocardiographically determined ejection fraction (EF) and that determined from the relationship of the PEP and the LVET according to the formula, EF = 1.25 -1.25 PEP/LVET. The LVETI was, where so indicated, corrected for diurnal effects as reported by Weissler and associates.12 At least 10 consecutive cardiac cycles were analyzed. Careful checks on consistency and accuracy were made by frequent independent determinations of similar sequences by each of two of the authors (K. N. and W. S.). Procedures Intravenous Digitoxin Digitoxin, 0.8 mg, was given intravenously to 10 patient volunteers after control samples of blood had been obtained, and systolic intervals determined. These procedures were done at approximately 7:30 a.m. Subsequent blood sampling and systolic interval determinations were performed in 2, 4, 6, and 24 hours, in six patients in 48 hours, and in three patients in 72 hours. The environmental circumstances during these studies deserve note. The patients were allowed to partake of their usual meals. Between determinations they were allowed to walk about or sit in the hospital corridors and in their rooms. They were brought to the laboratory 30 min prior to each determination in order to rest in the supine position before each measurement; blood was drawn after systolic interval determinations. The digitoxin series of experiments was performed during the course of a heat wave in an unairconditioned environment. The temperature-in the laboratory in which the study was done ranged between 80 
Results
Intravenous Digitoxin
Selected data obtained before and after the intravenous administration of 0.8 mg of digitoxin are presented in figure 1 and table 1. Control plasma digitoxin level was 0.44 + 0.12 m,ug/ml; range, 0 to 0.9 m,ug/ml. The mean 2-hour level of 45.5 + 5.9 mug/ml declined toward the slow excretion slope within 4 hours. The 48 and 72-hour values reveal the gradual continued decline of plasma digitoxin concentration. The T½ of this slow decline was estimated to be 58 hours. Significant declines were seen in the LVETI and Q-S2 at 2 hours (P < 0.01), and these persisted at 24 hours (P < 0.05). The maximal inotropic effect appeared to occur at 4 hours, but the exact time of its occurrence could not necessarily be gleaned from the data because of the time increments chosen for the observations. Heart rate was essentially unchanged. The pre- Mean values for plasma digoxin in six young normal subjects followed 48 hours after 1 mg of digoxin was given intravenously. Mean values for plasma digitoxin and simultaneous alterations in LVETI for 10 subjects during the 24 hours following intravenous administration of 0.8 mg of digitoxin. ejection period and the derived ejection fraction were not significantly altered.
In the six subjects followed 48 hours, LVETI and Q-S2 continued to be significantly reduced. The three subjects followed longer had a mean plasma digitoxin value at 72 hours of 18.9 + 5.6 m,ug/ml, a decline of approximately 8 mug/ml from the value at 48 hours of 27 + 7.5 m,ug/ml. Their mean LVETI and Q-S2 were below the control value at 72 hours, but statistical significance was not present for these few observations.
Intravenous Digoxin
The mean plasma digoxin values following intravenous administration of 1.0 mg of digoxin are presented in figure 2 and The mean values for selected systolic time intervals and the associated mean plasma digoxin levels are seen in table 2 and figure 3. Significant decreases in LVETI and Q-S2 were seen 30 min after injection. The LVETI shortening progressed to its maximum at 3 and 4 hours. While the 24 and 48-hour values were significantly less than control, they were returning toward the initial value. A similar pattern of change was noted in the Q-S2 interval. The mean PEP decreased within the 024 24
HOURS
Figure 3 Mean values for plasma digoxin and simultaneous alterations in LVETI in six patients folowed 48 hours after 1 mg of digoxin was given intravenously.
Csrculation, Volusme XLII, December 1970 first 2 hours, but was not materially different from control afterward. Heart rate, ejection fraction, S1-S2, isovolumic contraction time, and Q-1 were not significantly altered. The T½ of the ALVETI derived from the slope of these values was approximately 29 hours.
The maximal inotropic effects seen at 3 and 4 hours, as determined from the maximum ALVETI, occurred as plasma digoxin declined into a slow excretion phase. During the rapid early fall of the plasma level, inotropic effects began. During the subsequent slow decline, the inotropic effects, as reflected in shortened LVETI and Q-S2, paralleled the plasma digoxin values. The availability of plasma glycoside determinations, a long sought-after achievement, may provide important clinical information if the relationships of these measurements to onset and offset of myocardial effects of the drugs can be defined. The large plasma-tomyocardial tissue ratio of digoxin (at least 1:30)9' 10 and the reportedly wide range of myocardial tissue concentrations have led to the suggestion that little of importance concerning myocardial effects might be expected from plasma determination.'0 The present data suggest great value from properly timed plasma samplings.
A comparison of the early plasma levelphysiologic response relationship ( fig. 4) with gross myocardial tissue uptake may provide insight into the time required for digitalis glycosides to gain access to presumed active sites. The progressive slowing of the rapid, early decline in plasma digoxin may be related to a limited rate of uptake by such sites ( figs. 2 and 3) .
The patterns of change observed for plasma glycoside levels and the systolic intervals provide guide lines for optimal sampling time when these technics are employed clinically. During the plasma-tissue equilibration period, the values for digitoxin and digoxin rapidly, fall from their early peak levels while the systolic intervals are altered from control 22 Time of sampling following administration of the drug is another factor that could contribute toward obtaining falsely high or low levels.
